Literature DB >> 17532575

Evaluation of serum procalcitonin concentration in the ICU following severe burn.

L Bargues1, Y Chancerelle, J Catineau, P Jault, H Carsin.   

Abstract

The goal of the study was to analyse plasma procalcitonin (PCT) concentrations during infectious events of burns in ICU. Clinical and laboratory data were collected at admission and twice a week in burned patients admitted with a total body surface area (TBSA) >20%. Procalcitonin was determined using both a semi-quantitative detection (PCT-Q) and a quantitative immunoluminometric method (PCT-Lumi). A total of 359 time points in 25 consecutive patients with 40+/-17% (20-86%) TBSA burned, defined as a procalcitonin concentration associated with an inflammatory status according to society critical care medicine definition, were made. The principal site of infection was the respiratory tract (84% of patients required mechanical ventilation). PCT-Lumi values corresponded to the four semi-quantitative ranges of PCT-Q and statistically reflected the simultaneously observed inflammatory status (Kruskall-Wallis test). The area under the receiver operating characteristic curve for C-reactive protein (CRP) was higher than those for PCT and white blood cell (WBC) count, but this difference was not significant. The optimum PCT cut-off value was 0.534 ng/ml with sensitivity and specificity of 42.4% and 88.8%, respectively. However, PCT does not appear to be superior to C-reactive protein (CRP) and white blood count (WBC) as diagnosis marker of sepsis in burns. PCT is not sufficient to diagnose and to follow infection in burns admitted in ICU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532575     DOI: 10.1016/j.burns.2006.10.401

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  11 in total

1.  [Not Available].

Authors:  R Le Floch; E Naux; J F Arnould
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

2.  Procalcitonin: a diagnostic and prognostic biomarker of sepsis in burned patients.

Authors:  A Mokline; L Garsallah; I Rahmani; K Jerbi; H Oueslati; S Tlaili; R Hammouda; B Gasri; A A Messadi
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

3.  The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study.

Authors:  Juan J Egea-Guerrero; Carmen Martínez-Fernández; Ana Rodríguez-Rodríguez; Angélica Bohórquez-López; Angel Vilches-Arenas; María Pacheco-Sánchez; Juan M Guerrero; Francisco Murillo-Cabezas
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

4.  The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis.

Authors:  Luís Cabral; Vera Afreixo; Luís Almeida; José Artur Paiva
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

5.  Calcitonin gene-related peptide and thermal injury: review of literature.

Authors:  Giulio Gherardini; Giuseppe Curinga; Giuseppe Colella; Nicola Freda; Raffaele Rauso
Journal:  Eplasty       Date:  2009-07-28

Review 6.  Clinical review: the critical care management of the burn patient.

Authors:  Jane A Snell; Ne-Hooi W Loh; Tushar Mahambrey; Kayvan Shokrollahi
Journal:  Crit Care       Date:  2013-10-07       Impact factor: 9.097

7.  Predicting and managing sepsis in burn patients: current perspectives.

Authors:  Omar Nunez Lopez; Janos Cambiaso-Daniel; Ludwik K Branski; William B Norbury; David N Herndon
Journal:  Ther Clin Risk Manag       Date:  2017-08-29       Impact factor: 2.423

8.  Valuable prognostic indicators for severe burn sepsis with inhalation lesion: age, platelet count, and procalcitonin.

Authors:  Yichao Xu; Xinyuan Jin; Xiaonan Shao; Feng Zheng; Hong Zhou
Journal:  Burns Trauma       Date:  2018-10-29

9.  Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Margarida Marques; Isabel Tourais; Catarina Chaves; Luís Almeida; José Artur Paiva
Journal:  BMC Anesthesiol       Date:  2018-09-05       Impact factor: 2.217

Review 10.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.